Keytruda (pembrolizumab) is the first FDA approved immunotherapy drug that blocks the protein - receptor (programmed cell death - PD-1) allowing patients immune system to attack cancer.
Israel is one of the few countries allowed to use Keytruda not only for melanoma, but also as a new first-line treatment for lung cancer and for metastatic or recurrent small-cell neck or head carcinoma. Keytruda has been officially used in Israel since 2014 and has become a part of a "essential medicines package" in the following year.
The Israeli medical centers involved in the clinical trials of the drug detected improvement of treatment of melanoma without the side effects caused by traditional chemotherapy (like hair loss). The drugs also have shown promise as a “long-lasting” treatment for selected oncological diseases, but doctors continue to learn more as the drugs are used outside of clinical trials.
Tested at Sheba Medical Center, Keytruda deals with tumors using the body’s own immune system. An Israeli-tested drug was a key in helping former US president Jimmy Carter in his fight with life-threatening tumors after he was diagnosed with melanoma at the end of 2015.
The course of treatment for each patient is different. Israeli oncologists determine the number of procedures based on experience in chemotherapy and patient's general medical state.
Bookimed does not add extra charges for Immunotherapy with Keytruda (Pembolizumab) prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Immunotherapy with Keytruda (Pembolizumab) upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
| The USA | Turkey | Mexico | |
| Immunotherapy with Keytruda (Pembolizumab) | from $21900 | from $7300 | from $8395 |
Submit a request on Bookimed to has a diagnosis at Sourasky or calculate Pembrolizumab cost for your case.
Sheba Medical Center is one of the best hospitals in Israel and in the world. Newsweek International Magazine ranked Sheba Hospital in TOP 10 world's hospital in 2020. The hospital covers 1,990 specialties and over 1,500,000 patients all around the world visit Sheba Hospital for treatment every year.
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Dr. David Sarid is a specialist in oncology and radiotherapy based in Israel with expertise in chemotherapy, radiotherapy, and biological cancer therapy. He has been educated in the UK, Israel, and Georgia and has written over 30 articles devoted to cancer treatment. He is a lecturer at Tel Aviv University and a member of several medical organizations.
Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).
Specialty:
Education and specialization:
Membership:
Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.